CLINICAL_TRIALS
trial_result
· 2020-11-12
Clinical Trial Update: A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy [Phase 3]
Summary
Phase 3 trial assessing the efficacy and safety of JZP-258 in narcolepsy with cataplexy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy With Cataplexy | Phase 3 | Status: COMPLETED | Results posted: 2020-11-12